Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.
Authors : Lewiecki E M EM; Cooper C C; Thompson E E; Hartl F F; Mehta D D; Papapoulos S E SE;
Affiliations : New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
Journal : N/A (2010)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...